1. "Department of Medicine"
Formats
  1. Journal Article (19347)
  2. Meeting Abstract (15823)
  3. Review (1102)
  4. Book Section (924)
  5. Editorial (580)
  6. Research Letter (301)
  7. Conference Paper (299)
  8. Guidelines (285)
  9. Correspondence (226)
  10. Miscellaneous (87)
  11. Book Whole (61)
Groups
  1. Department of Medicine (39035)
  2. Solid Tumor Oncology Division (22035)
  3. Hematologic Malignancies, Division of (13004)
  4. Center for Hematologic Malignancies (10842)
  5. GSK Faculty (10530)
  6. Survivorship Research (9202)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Sergio Giralt (1050)
  4. Miguel-Angel Perales (913)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (643)
  2. 2024 (2141)
  3. 2023 (2451)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2560)

More Years

Publications
  1. Journal of Clinical Oncology (6050)
  2. Blood (3572)
  3. Annals of Oncology (1395)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (890)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6364)
  2. Elsevier Inc. (4610)
  3. American Society of Hematology (3843)
  4. American Association for Cancer Research (2879)
  5. Oxford University Press (2271)
  6. Nature Publishing Group (2080)

More Publishers

Results (39035)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: Results from a North American expanded access program (CheckMate 218)
    Journal Article

    Hodi, F. S.; Chapman, P. B.; Sznol, M.; Lao, C. D.; Gonzalez, R.; Smylie, M.; Daniels, G. A.; Thompson, J. A.; Kudchadkar, R.; Sharfman, W.; more...
    Melanoma Research (2021)

    Fulltext@MSK | Save
  • CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: An open-label, multicentre, phase 1b study
    Journal Article

    O'Hara, M. H.; O'Reilly, E. M.; Varadhachary, G.; Wolff, R. A.; Wainberg, Z. A.; Ko, A. H.; Fisher, G.; Rahma, O.; Lyman, J. P.; Cabanski, C. R.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: A safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database
    Journal Article

    Morice, P. M.; Leary, A.; Dolladille, C.; Chrétien, B.; Poulain, L.; González-Martín, A.; Moore, K.; O'Reilly, E. M.; Ray-Coquard, I.; Alexandre, J.
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • The management of metastatic GIST: Current standard and investigational therapeutics
    Review

    Kelly, C. M.; Gutierrez Sainz, L.; Chi, P.
    Journal of Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
    Review

    Lumish, M.; Falchi, L.; Imber, B. S.; Scordo, M.; von Keudell, G.; Joffe, E.
    Journal of Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • Mutant isocitrate dehydrogenase 1 inhibitor ivosidenib in combination with azacitidine for newly diagnosed acute myeloid leukemia
    Journal Article

    DiNardo, C. D.; Stein, A. S.; Stein, E. M.; Fathi, A. T.; Frankfurt, O.; Schuh, A. C.; Döhner, H.; Martinelli, G.; Patel, P. A.; Raffoux, E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Mutant SF3B1 promotes AKT- and NF-κB-driven mammary tumorigenesis
    Journal Article

    Liu, B.; Liu, Z.; Chen, S.; Ki, M.; Erickson, C.; Reis-Filho, J. S.; Durham, B. H.; Chang, Q.; de Stanchina, E.; Sun, Y.; more...
    Journal of Clinical Investigation (2021)

    Fulltext@MSK | Save
  • NCCN Guidelines Insights: Acute myeloid leukemia, version 2.2021: Featured updates to the NCCN Guidelines
    Guidelines

    Pollyea, D. A.; Bixby, D.; Perl, A.; Bhatt, V. R.; Altman, J. K.; Appelbaum, F. R.; de Lima, M.; Fathi, A. T.; Foran, J. M.; Gojo, I.; more...
    Journal of the National Comprehensive Cancer Network (2021)

    Fulltext@MSK | Save
  • Apples and oranges? Considerations for EHR-based analyses aggregating data from interventional clinical trials and point-of-care encounters in oncology
    Editorial

    Lavery, J. A.; Callahan, M. K.; Panageas, K. S.
    JCO Clinical Cancer Informatics (2021)

    Fulltext@MSK | Save
  • Genetic/Familial High-Risk Assessment: Breast, Ovarian, And Pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology
    Guidelines

    Daly, M. B.; Pal, T.; Berry, M. P.; Buys, S. S.; Dickson, P.; Domchek, S. M.; Elkhanany, A.; Friedman, S.; Goggins, M.; Hutton, M. L.; more...
    Journal of the National Comprehensive Cancer Network (2021)

    Fulltext@MSK | Save